Promethazine: Clinical Trials

34 trials of Promethazine, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

23 completed, 6 terminated, 3 unknown, 1 not yet recruiting. 9 Phase 3, 9 Phase 4, 7 Not applicable, 5 Phase 2, 3 Phase 1.

By phase and status

PhaseTrialsStatus
Phase 39Completed 6, Terminated 2, Unknown 1
Phase 49Completed 9
Not applicable7Completed 3, Terminated 3, Not yet recruiting 1
Phase 25Completed 3, Terminated 1, Unknown 1
Phase 13Completed 2, Recruiting 1
Early Phase 11Unknown 1

Follow Promethazine: new trials by email Literature Review of Promethazine trials Research Report on Promethazine

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Safety and Preliminary Efficacy of Hibernation-Like Therapy (Chlorpromazine and Promethazine) in Patients With Acute Ischemic Stroke (AIS) Eligible for Reperfusion Therapy.
Hibernation-like Therapy (Chlorpromazine and Promethazine, C+P) - Acute Ischemic Stroke
Not applicableNot yet recruitingJi Xunming,MD,PhD572026-01-012026-01-23
Study on Hibernation-like Therapy Based on Mechanical Thrombectomy
chlorpromazine and promethazine, Placebo group, endovascular thrombectomy - Acute Ischemic Stroke
Phase 1RecruitingCapital Medical University322024-11-092024-12-20
Combination of Intranasal Scopolamine and Sensory Augmentation to Mitigate G-transition Induced Motion Sickness and Enhance Sensorimotor Performance
DPI-386 Nasal Gel, Other (e.g., promethazine, meclizine) - Motion Sickness, Space, Motion Simulation
Phase 2UnknownRepurposed Therapeutics, Inc.802021-08-102024-05-16
Treatment of Pruritus With Intramuscular Promethazine
Promethazine, Placebo - Pruritus, Pregnancy Related
Phase 4CompletedUniversity of Florida722021-08-092025-05-04
TREC-Lebanon: A Trial for Rapid Tranquilisation for Agitated Patients in the Emergency Setting
Haloperidol + Promethazine + Chlorpromazine, Haloperidol + Promethazine - Psychiatric Emergency, Aggression
Phase 4CompletedJoseph Dib1002018-08-282022-06-14
Therapeutic Rest to Delay Admission in Early Labor: A Prospective Study on Morphine Sleep
Morphine Sulfate and Promethazine - Labor Pain, Early Labor
CompletedUniversity of California, San Francisco822017-09-272020-07-29
A Controlled Study to Determine the Efficacy and Safety of CL-108 5 mg for Acute Pain and the Prevention of OINV
CL-108 5 mg, Norco, Placebo - Pain, Nausea
Phase 3CompletedCharleston Laboratories, Inc3492017-08-022023-03-22
Treatment Modalities of Oral Lichen Planus
Dexamethasone - Oral Lichen Planus
Early Phase 1UnknownUniversity of Faisalabad322017-06-012017-08-02
Fundamental Modification of the Gut Microbiota in the Treatment of Refractory Crohn's Disease
Fluconazole, Vancomycin, Neomycin - Crohn's Disease
Phase 2CompletedUniversity of Pennsylvania82016-08-012024-02-06
Real-time Decision Support for Postoperative Nausea and Vomiting (PONV) Prophylaxis
Automated recommendation at the start of the case, Automated notification at the start of surgery, Preoperative recommendations: by email - Postoperative Nausea and Vomiting
Not applicableCompletedVanderbilt University270342016-07-012019-03-07
Intraoperative Acupoint Stimulation to Prevent Post-Operative Nausea and Vomiting (PONV)
Electrical Stimulation, Zofran, Dexamethasone - Post-Operative Nausea and Vomiting, Breast Cancer
Not applicableCompletedM.D. Anderson Cancer Center1882016-03-012025-12-05
Pharmacovigilance in Gerontopsychiatric Patients
Phenobarbital, Phenytoin, Carbamazepine - Dementia, Depression
Phase 3TerminatedHannover Medical School4072015-01-012018-02-28
A Four-Period, Four-Treatment, Four-Way Relative Bioavailability Study of CL-108 Under Fed and Fasted Conditions
CL-108, Vicoprofen, Ultracet - Healthy
Phase 1CompletedCharleston Laboratories, Inc202014-11-012017-05-02
A Double-Blind, Randomized, Active- and Placebo-Controlled, Multiple-Dose Multi-Center Phase 3 Study of the Safety and Efficacy of CL-108 in the Treatment of Moderate to Severe Acute Pain and Opioid-Induced Nausea and Vomiting (OINV)
CL-108 (hydrocodone 7.5 mg, acetaminophen 325 mg, promethazine 12.5 mg), Placebo, Norco (hyrdocodone 7,5 mg, acetaminophen 325 mg) - Pain, Nausea
Phase 3CompletedJoseph Hazelton5522014-09-012016-11-03
Study of Promethazine for Treatment of Diabetic Gastroparesis
Promethazine, Sugar pill - Diabetic Gastroparesis
Phase 2TerminatedDartmouth-Hitchcock Medical Center32014-07-012018-08-07
Countermeasures to Reduce Sensorimotor Impairment and Space Motion Sickness Resulting From Altered Gravity Levels
Promethazine, Hyper gravity training, Placebo - Vestibular
Phase 4CompletedFaisal_Karmali@MEEI.HARVARD.EDU302014-06-012018-01-08
Promethazine vs. Lorazepam for Treatment of Vertigo
Promethazine, Lorazepam - Peripheral Vertigo.
Phase 3CompletedShahid Beheshti University of Medical Sciences2102013-04-012013-06-14
Phase III Study of the Safety and Efficacy of Cl-108 in the Treatment of Moderate to Severe Pain
CL-108 (hydrodocone 7.5 mg, acetaminophen 325 mg, promethazine 12.5 mg), Placebo - Pain, Nausea
Phase 3CompletedCharleston Laboratories, Inc4602013-01-012016-11-03
Single Dose Pharmacokinetics of Suboxone Study in Hepatic Impaired Subjects
2.0mg Buprenorphine/0.5mg Naloxone, Promethazine - Hepatic Failure, Hepatic Impairment
Phase 4CompletedIndivior Inc.432012-09-012016-10-24
Reletex Versus Standard of Care Therapy for Post-Operative Nausea Control in Patients Undergoing Foregut Surgery
Reletex, IV ondansetron 4 mg q 6 hours for a total of 4 doses, IV promethazine 25 mg q 6 hours prn - Nausea and Vomiting Post-foregut Surgery
Not applicableCompletedKyle A Perry1002011-08-012014-03-05

Showing 20 of 34. Sign in to see all of them.

Conditions studied

Nausea (10)  ·  Vomiting (8)  ·  Postoperative Nausea and Vomiting (4)  ·  Pain (3)  ·  Aggression (2)  ·  Ischemic Stroke (2)  ·  Labor Pain (2)  ·  Anxiety Disorders (1)  ·  Breast Neoplasms (1)  ·  Crohn Disease (1)  ·  Dementia (1)  ·  Depression (1)  ·  Hepatitis C (1)  ·  Hyperemesis Gravidarum (1)  ·  Hypersensitivity (1)

Sponsors

Charleston Laboratories, Inc (3)  ·  Vanderbilt University (2)  ·  Capital Medical University (1)  ·  Christian Medical College, Vellore, India (1)  ·  Christiana Care Health Services (1)  ·  Dartmouth-Hitchcock Medical Center (1)  ·  Faisal_Karmali@MEEI.HARVARD.EDU (1)  ·  HaEmek Medical Center, Israel (1)  ·  Hannover Medical School (1)  ·  Indivior Inc. (1)  ·  Ji Xunming,MD,PhD (1)  ·  Joseph Dib (1)  ·  Joseph Hazelton (1)  ·  Kyle A Perry (1)  ·  M.D. Anderson Cancer Center (1)

Countries

United States (19)  ·  Iran (2)  ·  Canada (1)  ·  China (1)  ·  Germany (1)  ·  India (1)  ·  Israel (1)  ·  Lebanon (1)  ·  Pakistan (1)  ·  Sri Lanka (1)

Top investigators

Adam Wendling, MD (1)  ·  Alberto A Uribe, M.D. (1)  ·  Alice P Chen, M.D. (1)  ·  Alicia M. Kowalski, MD (1)  ·  Asita de Silva (1)  ·  Bernard Schachtel, MD (1)  ·  Brian E. Lacy, MD (1)  ·  Darren A Braude, MD, MPH (1)  ·  Eric J. Lawitz, MD (1)  ·  Faisal Karmali, Ph.D. (1)  ·  Helge Frieling, Prof., MD (1)  ·  Irwin Plisco, M.D. (1)  ·  James D Lewis, MD, MSCE (1)  ·  Jean Kronberg, MD, PhD (1)  ·  Jonathan P Wanderer, MD, MPhil (1)

Results publications

PMID 10078396, PMID 10475299, PMID 10485781, PMID 10624646, PMID 10730546, PMID 10910848, PMID 11050519, PMID 11454483, PMID 12818945, PMID 14504060, PMID 14620731, PMID 15064259, PMID 15120791, PMID 15139789, PMID 16528908, PMID 16597655, PMID 16766588, PMID 16934536, PMID 17954514, PMID 18304050, PMID 18633021, PMID 18633022, PMID 18633025, PMID 1881539, PMID 20825792, PMID 21572992, PMID 25603822, PMID 25971957, PMID 26067128, PMID 26870733, PMID 2689885, PMID 27462117, PMID 27521593, PMID 28439720, PMID 28919116, PMID 28973661, PMID 29129157, PMID 29674752, PMID 32528650, PMID 33545440, PMID 36302173, PMID 747719, PMID 7848959, PMID 9400355